Clinical Trials Browser

Phase 3 × INDUSTRY × Platinum-sensitive Relapsed Ovarian Cancer × Clear all

NCT03705156 2023-04-13

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Phase 3 Unknown

Platinum-sensitive Relapsed Ovarian Cancer